MAVS: a new weapon in the fight against viral infections

Recent Pat Endocr Metab Immune Drug Discov. 2013 May;7(2):115-9. doi: 10.2174/1872214811307020004.

Abstract

In addition to their participation in metabolic processes and control of programmed cell death, the role of mitochondria as a fundamental hub for innate anti-viral immunity is now emerging. The participation of the mitochondrial antiviral signaling protein (MAVS) as a central regulator of a complex signaling cascade, which results in the induction of antiviral and inflammatory responses has been described. A patent based on this role of MAVS is highlighted in this review.

Publication types

  • Review

MeSH terms

  • Adaptor Proteins, Signal Transducing / metabolism*
  • Animals
  • Antiviral Agents / pharmacology*
  • Drug Design
  • Humans
  • Immunity, Innate / drug effects
  • Mitochondria / drug effects*
  • Mitochondria / immunology
  • Mitochondria / metabolism
  • Mitochondria / virology
  • Patents as Topic
  • Signal Transduction / drug effects
  • Virus Diseases / drug therapy*
  • Virus Diseases / immunology
  • Virus Diseases / metabolism
  • Virus Diseases / virology

Substances

  • Adaptor Proteins, Signal Transducing
  • Antiviral Agents
  • MAVS protein, human